会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 5. 发明申请
    • Compositions of ezetimibe and methods for the treatment of cholesterol-associated benign and malignant tumors
    • 依泽替米贝的组合物和治疗胆固醇相关良性和恶性肿瘤的方法
    • US20070037755A1
    • 2007-02-15
    • US11485773
    • 2006-07-13
    • Carl SchaffnerKeith SolomonMichael Freeman
    • Carl SchaffnerKeith SolomonMichael Freeman
    • A61K31/7052A61K31/397
    • A61K31/7052A61K31/397A61K45/06A61K2300/00
    • A method of prevention or treatment of a cholesterol-associated tumor is provided which comprises administering a therapeutically effective amount of an azetidinone-based cholesterol absorption inhibitor, preferably ezetimibe (SCH 58235) and/or its phenolic glucuronide, or at least one ezetimibe analog, e.g., SCH 48461 and SCH 58053, to a patient wherein the patient is either at risk of developing a cholesterol-associated tumor or already exhibits a cholesterol-associated tumor. Formulations of ezetimibe are also provided for the prevention or treatment of a cholesterol-associated tumor further comprising at least one other anticancer agent. An article of manufacture is also provided which comprises a container, instructions, and a composition, wherein the composition comprises a therapeutically effective amount of an azetidinone-based cholesterol absorption inhibitor, preferably ezetimibe or its phenolic glucuronide, and the instructions are for the administration of the composition for the prevention or treatment of a cholesterol-associated tumor.
    • 提供了预防或治疗胆固醇相关肿瘤的方法,其包括施用治疗有效量的基于氮杂环丁酮的胆固醇吸收抑制剂,优选依泽替米贝(SCH 58235)和/或其酚醛葡糖苷酸,或至少一种依泽替米贝类似物, 例如SCH 48461和SCH 58053,其中患者处于发展为胆固醇相关肿瘤或已经表现出胆固醇相关肿瘤的风险。 还提供了依泽替米贝的制剂用于预防或治疗进一步包含至少一种其它抗癌剂的胆固醇相关肿瘤。 还提供了一种制品,其包括容器,说明书和组合物,其中所述组合物包含治疗有效量的基于氮杂环丁酮的胆固醇吸收抑制剂,优选依泽替米贝或其酚醛葡糖苷酸,并且所述说明书用于给予 用于预防或治疗胆固醇相关肿瘤的组合物。
    • 6. 发明申请
    • Methods and systems for dispersing ultrafine non-polar particles into a polymer/solvent/non-solvent solution and products formed thereby
    • 将超细非极性粒子分散到聚合物/溶剂/非溶剂溶液中的方法和系统以及由此形成的产物
    • US20070023354A1
    • 2007-02-01
    • US11189662
    • 2005-07-26
    • Keith Solomon
    • Keith Solomon
    • B01D71/06
    • C08L77/00B01D67/0079B01D69/141B01D69/147B01D2325/24B01F3/1242C01P2004/02C08J3/205C09C1/56Y10T428/31739
    • A method for producing a homogeneous and stable dispersion of ultrafine non-polar particles in a ternary polymer/solvent/non-solvent solution (dope) suitable for phase inversion formation into a controlled pore size microporous polymer membrane wherein the polymer contains homogeneously distributed ultrafine non-polar particles is disclosed. In one possible embodiment, the ultrafine non-polar particles are ultrasonically dispersed in at lest one portion of the solvent and is then added to the balance of an optionally separately prepared solvent/non-solvent solution. Subsequently, the polymer is added to and dissolved in the solvent/non-solvent/particle dispersion with the resulting solution being cast into a liquid film and subjected to phase inversion processing is disclosed The resulting polymeric microporous membranes containing highly dispersed and homogeneously distributed ultrafine non-polar particles are also disclosed.
    • 一种用于在适合相转化形成控制孔径微孔聚合物膜的三元聚合物/溶剂/非溶剂溶液(涂料)中制备超细非极性颗粒的均匀且稳定的分散体的方法,其中聚合物含有均匀分布的超细非极性 公开了极性颗粒。 在一个可能的实施方案中,将超细非极性颗粒超声分散在溶剂的至少一部分中,然后加入余下的任选单独制备的溶剂/非溶剂溶液中。 随后,将聚合物加入并溶解在溶剂/非溶剂/颗粒分散体中,将所得溶液流延成液膜并进行相转化处理。所得聚合物微孔膜含有高度分散且均匀分布的超细非极性 也公开了极性颗粒。